N

Neurocrine Biosciences
D

NBIX

125.670
USD
0.64
(0.51%)
Market Closed
Volume
53,262
EPS
5
Div Yield
-
P/E
34
Market Cap
12,723,699,305
OverviewSignalsIdeasNews
Related Instruments
    A
    ACAD
    -0.240
    (-1.41%)
    16.790 USD
    A
    ALKS
    -0.150
    (-0.53%)
    28.200 USD
    A
    AVDL
    -0.670
    (-5.79%)
    10.910 USD
    E
    ESPR
    0.03000
    (1.43%)
    2.13000 USD
    I
    INSM
    -4.950
    (-6.95%)
    66.310 USD
    S
    SAGE
    -0.26000
    (-4.84%)
    5.11000 USD
    S
    SRPT
    -4.470
    (-4.10%)
    104.600 USD
    T
    TEVA
    -0.315
    (-1.88%)
    16.440 USD
    More
News

Title: Neurocrine Biosciences

Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Neurocrine Biosciences Inc is a research-based pharmaceutical company advancing drug candidates in the central nervous system and endocrine-related categories. The company's three late stage clinical programs are elagolix which is hormone releasing antagonist for women's health, opicapone which is an inhibitor for parkinson's patients, and ingrezza for tourette syndrome.